Ticker
VRCACompany Name
VERRICA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Core Assets | Goodwill and Intangibles |
---|---|---|---|---|
6/30/2025 | $ 39.11M | $ 15.4M | $ 23.71M | $ 0 |
3/31/2025 | $ 42.18M | $ 29.59M | $ 12.58M | $ 0 |
12/31/2024 | $ 54.13M | $ 46.33M | $ 7.8M | $ 0 |
9/30/2024 | $ 32.93M | $ 22.96M | $ 9.97M | $ 0 |
6/30/2024 | $ 52.01M | $ 31.93M | $ 20.08M | $ 0 |
3/31/2024 | $ 66.31M | $ 48.94M | $ 17.37M | $ 0 |
12/31/2023 | $ 81.6M | $ 69.55M | $ 12.05M | $ 0 |
9/30/2023 | $ 97.15M | $ 84.31M | $ 12.84M | $ 0 |
6/30/2023 | $ 62.2M | $ 55.14M | $ 7.06M | $ 0 |
3/31/2023 | $ 68.64M | $ 59.95M | $ 8.69M | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for VERRICA PHARMACEUTICALS INC is calculated as follows: Assets [ $ 79.94M ] - Intangibles [ $ 0 ] - CashnEq [ $ 17.2M ]
(=) Core Assets [ $ 62.74M ]
Minimum
Jun 30, 2023
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.42K |
---|---|
min | $ 0 |
max | $ 4.36B |
average | $ 798.36M |
median | $ 287.51M |
std | $ 1.05B |